Celsis Limited

Active02695296 Private limited company
Incorporated
9 March 1992 (34 years)
Previously known as
Charles River Microbial Solutions International Limited (until 21 September 2016)
Celsis Limited (until 28 June 2016)
Skychase Limited (until 29 April 1992)
Industry
Manufacture of other chemical products n.e.c. (20590)
Manufacture of electronic measuring, testing etc. equipment, not for industrial process control (26511)
Other research and experimental development on natural sciences and engineering (72190)
Directors
Kevin John Finn
Owned by
Charles River Laboratories (Holdings) Limited
Accounts type
Full
Region
South East
Address
Charles River Laboratories
Manston Road
Margate
CT9 4LT

Filing status

Accounts due
30 September 2027
Last accounts
27 December 2025
Conf. stmt due
19 May 2027
Last conf. stmt
5 May 2026

Charges

Total
6
Outstanding
0
Part satisfied
0
Satisfied
6

Officers 3 active

Officer details are public data from the Companies House register.

Director · Appointed 29 September 2025
American
Born August 1980 (46)
Finn, Kevin John
Director · Appointed 11 May 2022
American
Born July 1971 (55)
Galli, Jon
Secretary · Appointed 1 January 2021
Officer history (35 former)
29 September 2025
Resigned Pease, Flavia Houaiss as Director
29 September 2025
Appointed Dolph, Kerstin Susanne as Director
11 May 2022
Resigned Jordan, Foster Timmons as Director
11 May 2022
Resigned Smith, David Ross as Director
11 May 2022
Appointed Finn, Kevin John as Director
11 May 2022
Appointed Pease, Flavia Houaiss as Director
1 January 2021
Appointed Galli, Jon as Secretary
31 December 2020
Resigned Price, Sarah Margaret as Secretary
23 December 2019
Resigned Montana, John Gary, Dr as Director
5 December 2017
Appointed Montana, John Gary, Dr as Director
1 November 2017
Resigned Hilyard, Katherine Louise, Dr as Director
24 July 2015
Appointed Price, Sarah Margaret as Secretary
24 July 2015
Appointed Smith, David Ross as Director
24 July 2015
Appointed Jordan, Foster Timmons as Director
24 July 2015
Appointed Hilyard, Katherine Louise, Dr as Director
24 July 2015
Resigned Pilarczyk, Michael Lee as Secretary
24 July 2015
Resigned Lecoque, Jay Charles as Director
16 April 2012
Resigned Pilarczyk, Michael Lee, Mr. as Director
30 June 2011
Resigned Madrolle, Christian Serge as Director
30 June 2011
Resigned Madrolle, Christian Serge as Secretary
30 June 2011
Appointed Pilarczyk, Michael Lee as Secretary
1 June 2011
Appointed Pilarczyk, Michael Lee, Mr. as Director
1 October 2009
Resigned Celsis Limited as Corporate Director
1 October 2009
Appointed Madrolle, Christian Serge as Director
3 September 2009
Resigned Madrolle, Christian Serge as Director
3 September 2009
Resigned Rowell, Jack as Director
3 September 2009
28 February 2005
Resigned Grant, Peter Leonard, Dr as Director
31 December 2004
Resigned Morris, John Rankin as Director
14 September 2001
Appointed Madrolle, Christian Serge as Secretary
14 September 2001
Resigned Williams, Julia May as Secretary
1 February 2001
Appointed Lecoque, Jay Charles as Director
1 October 2000
Appointed Madrolle, Christian Serge as Director
1 October 2000
Appointed Celsis Limited as Corporate Director
30 April 2000
Resigned Andrews, Paul John as Director
29 February 2000
Appointed Rowell, Jack as Director
28 January 2000
Resigned Harris, Mark Malcolm as Secretary
28 January 2000
Appointed Williams, Julia May as Secretary
28 January 2000
Resigned Harris, Mark Malcolm as Director
19 April 1999
Appointed Andrews, Paul John as Director
11 March 1998
Resigned Holden, Arthur Leonard as Director
5 January 1998
Appointed Harris, Mark Malcolm as Secretary
5 January 1998
Resigned Clement, Mark Rowland as Secretary
5 January 1998
Appointed Harris, Mark Malcolm as Director
1 December 1997
Resigned Clement, Mark Rowland as Director
18 February 1997
Resigned Precious, John Richard as Director
31 October 1996
Resigned Kerton, Nicholas Anthony, Dr as Director
5 February 1996
Resigned Mckinley, John Aiken as Secretary
5 February 1996
Appointed Clement, Mark Rowland as Secretary
31 December 1995
Resigned Mckinley, John Aiken as Director
2 September 1994
Appointed Holden, Arthur Leonard as Director
1 April 1994
Appointed Mckinley, John Aiken as Director
31 March 1994
Resigned Martin, Anthony Francis, Doctor as Director
17 June 1993
Resigned Edge, William as Director
17 June 1993
Resigned Desforges, Malcolm as Director
17 June 1993
Resigned Mckinley, John Aiken as Director
4 June 1993
Appointed Kerton, Nicholas Anthony, Dr as Director
1 June 1993
Appointed Clement, Mark Rowland as Director
28 May 1993
Appointed Precious, John Richard as Director
28 May 1993
Appointed Grant, Peter Leonard, Dr as Director
15 March 1993
Appointed Martin, Anthony Francis, Doctor as Director
26 August 1992
Appointed Mckinley, John Aiken as Director
26 August 1992
Appointed Edge, William as Director
26 August 1992
Appointed Desforges, Malcolm as Director
22 April 1992
Appointed Morris, John Rankin as Director
11 March 1992
11 March 1992
Appointed Mckinley, John Aiken as Secretary
11 March 1992
Resigned Combined Secretarial Services Limited as Corporate Nominee Secretary
11 March 1992
Resigned Combined Secretarial Services Limited as Corporate Nominee Director
10 March 1992
Resigned Combined Nominees Limited as Corporate Nominee Director
9 March 1992
Appointed Combined Nominees Limited as Corporate Nominee Director
9 March 1992
Appointed Combined Secretarial Services Limited as Corporate Nominee Secretary
9 March 1992
Appointed Combined Secretarial Services Limited as Corporate Nominee Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Charles River Laboratories (Holdings) Limited
Corporate entity · Notified 18 June 2019
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited Company
Reg. no. 02829052
Former controllers (1)
18 June 2019
Ceased Celsis International Limited — Owns 75–100% of shares

Financials

Balance sheet as at 27 December 2025 · full accounts

Net Assets
£2,993,000
Turnover
£7,840,000
Profit Before Tax
£5,615,000
Employees
14
Current Ratio
5.4x
Profit Margin
72%
Return on Equity
140%

Trend

Turnover
£0 £5.0M £10.0M 2024 2025 £6,889,000 £7,840,000
Balance sheet detail
20252024
Fixed Assets£0£0
Current Assets£3,598,000£3,311,000
Creditors (< 1 year)£661,000£373,000
Net Current Assets£2,937,000£2,938,000
Net Assets£2,993,000£3,004,000
Shareholder Funds£2,993,000£3,004,000

Turnover£7,840,000£6,889,000
Cost of Sales£412,000£179,000
Gross Profit£7,428,000£6,710,000
Admin Expenses£1,899,000£1,832,000
Staff Costs£1,788,000£1,611,000
Operating Profit£5,529,000£4,878,000
Profit Before Tax£5,615,000£4,934,000
Tax£1,413,000£140,000
Profit for Period£4,202,000£4,794,000

Filings 228

DateDescriptionMade Up ToPagesPDF
30 June 2026Full accounts27 December 2025
19 May 2026Confirmation statement with no updates5 May 2026
3 October 2025Termination of appointment of a director
3 October 2025Appointment of a director
3 September 2025Full accounts28 December 2024
Show all 228 filings

Some other companies at this address

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?